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Abstract 
 
Coadministered pomegranate rind extract (PRE) and zinc (II) produces a potent 
virucidal activity against Herpes simplex virus (HSV); however, HSV infections are 
also associated with localised inflammation and pain. Here, the objective was to 
determine the anti-inflammatory activity and relative depth penetration of PRE, total 
pomegranate tannins (TPT) and zinc (II) in skin, ex vivo. PRE, TPT and ZnSO4 were 
dosed onto freshly excised ex vivo porcine skin mounted in Franz diffusion cells and 
analysed for COX-2, as a marker for modulation of the arachidonic acid inflammation 
pathway, by Western blotting and immunohistochemistry. Tape stripping was carried 
out to construct relative depth profiles. Topical application of PRE to ex vivo skin 
downregulated expression of COX-2, which was significant after just 6 h, and 
maintained for up to 24 h. This was achieved with intact stratum corneum, proving 
that punicalagin penetrated skin, further supported by the depth profiling data. When 
PRE and ZnSO4 were applied together, statistically equal downregulation of COX-2 
was observed when compared to the application of PRE alone; no effect followed the 
application of ZnSO4 alone. TPT downregulated COX-2 less than PRE, indicating that 
tannins alone may not be entirely responsible for the anti-inflammatory activity of 
PRE. Punicalagin was found throughout the skin, in particular the lower regions, 
indicating appendageal delivery as a significant route to the viable epidermis. Topical 
application of TPT and PRE had significant anti-inflammatory effects in ex vivo skin, 
confirming that PRE penetrates the skin and modulates COX-2 regulation in the 
viable epidermis. Pomegranates have potential as a novel approach in ameliorating 
the inflammation and pain associated with a range of skin conditions, including cold 
sores and herpetic stromal keratitis.  
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1. Introduction 
 
There is a clinical need for more and improved anti-inflammatory products. Many 
disease states are associated with inflammation. This is a natural response by the 
body’s defences and is essential in the tissue repair process; however, chronic 
inflammation is associated with pain and discomfort, and has been implicated as a 
preliminary stage in life-threatening conditions such as cancer and cardiovascular 
disease [1]. The immunologic basis for skin inflammation diseases such as psoriasis, 
allergic contact dermatitis and atopic dermatitis, with emphasis on potentially 
effective targets for novel anti-inflammatory drugs, was recently reviewed [2]. 
The processes involved in skin inflammation occur in the viable epidermis, 
which is largely composed of functional keratinocytes. During inflammatory 
challenge to the skin the keratinocytes respond by releasing cytokines and activating 
arachidonic acid metabolism along the COX-2 and lipoxygenase (LOX) pathways [3]. 
COX-2 is also rapidly upregulated upon chemical or mechanical tissue injury, 
signalling the arachidonic pathway to produce prostaglandin inflammatory mediators. 
The upregulation of COX-2 and LOX is transient with a short half-life and therefore 
is useful as a marker to determine the level of inflammation within skin at particular 
timepoints. Analysis of the level of COX-2 expression in skin ex vivo provides a 
comparative model for the anti-inflammatory anti- (or pro-) inflammatory responses 
of topically applied xenobiotics, and has been used to study for example n-3 fatty 
acids, ketoprofen and an extract of Harpagophytum procumbens have shown this 
[4,5]. 
 The pomegranate, fruit of the Punica granatum L. tree, has been used since 
ancient times to treat a wide range of ailments. Pomegranate rind extract (PRE) is 
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obtained from the pericarp (rind), which contains the highest concentration of 
phytochemicals, principally polyphenolic flavonols and ellagitannins, including 
ellagic acid and punicalagin. It has recently been shown that the innate antimicrobial 
activity of PRE is significantly potentiated by the co-administration of zinc (II) ions 
with up to 7-log reduction potency observed against Herpes simplex virus (HSV) - the 
causative microorganism of anogenital herpes and oral coldsores [6]. HSV type 1 and 
2 lesion eruptions cause a significant level of inflammation to the localised area, 
resulting in erythema, swelling and pain, particularly in the later stages of infection. 
Furthermore, other HSV-related conditions, such as herpetic stromal keratitis, are also 
associated with upregulated COX-2 expression [7].  
 Although challenging the virus is the primary concern when treating such 
conditions, a substantial vital load reduction would take time to feedback into a 
reduction of inflammation. Thus there would be distinct advantages if a medication 
could simultaneously address this inflammation-mediated discomfort and appearance 
directly. In terms of a pomegranate-based product, the notion is underpinned by a 
growing body of work including two reviews that illustrate the beneficial effects of 
pomegranate extracts as potential inflammation treatments [8,9]. The positive effect 
of the consumption of pomegranate extracts and juice has been demonstrated in 
relation to inflammation in the gastrointestinal tract, where ellagic acid was stated as 
the responsible agent [10,11].  Polyphenolics of differing structure regulate 
inflammation-involved pathways in different ways while attenuating colitis [12]. The 
flavanol quercetin, was found to suppress the expression of COX-2 mRNA in the 
pouch exudates cells of a rat paw, indicating that the anti-inflammatory action of 
quercetin may partly due to suppressing the up-regulation of COX-2 [13]; 
 6   
pomegranate aqueous extract was found to inhibit COX expression in mice [14] and 
reduce inflammatory processes in patients with type-2 diabetes [15].   
  The purpose of this study was to probe the effect of topically applied PRE, 
purified tannins (TPT) and ZnSO4 on COX-2 expression following their individual 
application, or in combination, on porcine skin ex vivo. Porcine ears have been used 
extensively as an acceptable model for human skin in the percutaneous penetration of 
xenobiotics [16,17]. Anti-inflammatory effects were assessed using Western blotting 
and immunocytochemistry to determine the modulation of endogenous epidermal 
COX-2 levels. Skin penetration depth profiles were also determined for punicalagin 
and Zn (II) by tape stripping. 
 
2. Materials and methods 
 
2.1. Materials 
 Pomegranates, of Spanish origin, were obtained from a local supermarket. 
Radioimmunoprecipitation assay buffer (RIPA buffer, comprised of 50 mM tris-HCl 
(pH 7.4), 1 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 150 mM NaCl, 
0.1% SDS, 1 mM phenylmethylsulfonyl fluoride serine protease inhibitor), Hanks 
balanced salt solution (HBSS), gentamycin sulphate, Ponseau S, PBS + 0.05% 
TWEEN, aprotinin, leupeptin, anti-actin antibody, sodium azide, SDS 10%, paraffin 
wax pellets, phosphate buffer saline pH 7.4 (PBS), methyl green, 
distyrene/plasticizer/xylene (DPX mountant) and λ-carrageenan were all purchased 
from Sigma-Aldrich, Poole, UK. Zinc sulphate (ZnSO4), potassium hydrogen 
phthalate, trifluoroacetic acid and HPLC-grade solvents were obtained from Fisher 
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Scientific (Loughborough, England). Primary COX-2 antibody (#4842) was 
purchased from Cell Signalling Technology (Boston, USA). Horseradish peroxidase 
(HRP)-labelled anti-rabbit polymer, DAB chromagen plus substrate was purchased 
from Dako UK (Ely, England). Western blocking reagent was from Roche 
Diagnostics, GmbH (Mannheim, Germany). Rainbow Marker (10-250 Kd), anti-
mouse HRP, (HRP)-linked antibody were from Amersham Biosciences Ltd 
(Amersham, UK). Dura substrate was from Perbio, Cramlington, UK, and 3,3'-
Diaminobenzidine (DAB) chromagen-AB substrate was from Abcam, Cambridge, 
UK. Freshly excised porcine ears were obtained from a local abattoir prior to steam 
cleaning and immersed in iced Hanks buffer before being subjected to laboratory 
experimentation within 1 h. As these were excised from freshly slaughtered pigs their 
use was not subject to ethical approval.   
 
2.2. Preparation of Pomegranate Rind Extract (PRE)  
 
 The rinds of 6 pomegranates (of Spanish origin) were excised by scalpel and 
cut into thin strips, blended in deionised H2O (25% w/v) and boiled for approximately 
10 min. The crude solution was then transferred into 50 mL screw-capped tubes and 
centrifuged at 10,400g at 4°C for 30 min using a Beckman Coulter Avanti J25 
Ultracentrifuge and vacuum filtered through a Whatman 0.45 m nylon membrane 
filter (Fisher Scientific, Loughborough, UK) before being freeze-dried and stored at -
20°C until required. The PRE was reconstituted in pH 4.5 phthalate buffer by adding 
2 mg to 10 mL buffer and sonicated for 10 min at 50-60 Hz until fully dissolved - this 
particular buffer and pH were used as it provided the optimum activity against HSV 
[6]. Punicalagin was analysed by HPLC (section 2.8.) and consisted of 20% w/w of 
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the freeze-dried PRE. The chemical structure and a chromatogram of punicalagin 
showing its composition of two anomers is shown in Figure 1. 
 
2.3. Preparation of Total Pomegranate Tannins (TPT) and Tannin-Free Fraction 
(TFF)  
 
 Total pomegranate tannins (TPT) is the purified form of PRE which has been 
stripped of its non-polyphenolic constituents and was prepared by column 
chromatography using a glass column slurry packed with 75g of Amberlite XAD-16 
resin in H2O [18]. The resin was washed with 300 mL methanol then 100 mL H2O 
and left for 12 h to equilibrate. A mass of 5 g PRE (dry weight) was loaded onto the 
column - the optimal loading volume 40 ± 5 mL per 75g of preconditioned XAD-16 
resin per column and was eluted with 300 mL of H2O until the pale yellow tannin-free 
fraction (TFF) was fully removed. The remaining tannins were eluted with 100 mL 
MeOH to yield a dark red TPT solution, which was dried under vacuum to yield TPT 
(freeze dried yield 1.3 g, 26%) and TFF (freeze dried yield 3.4 g, 68%). It was 
determined that this fraction contained 1.09 g of punicalagin (84% of the TPT 
fraction), and 0.009 g of ellagic acid (0.69%). These findings are in accordance with 
the literature which states that punicalagin was equivalent to 80-85% and ellagic acid 
1.3% of the total pomegranate tannin content [18]. HPLC revealed no evidence of 
tannins present within the TFF fraction (not shown).   
 
2.4. Ex Vivo Skin Preparation and Topical Delivery 
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 The ears were excised immediately post mortem and immersed in iced Hanks 
buffer, before arriving in the laboratory within 1 hour. The ears were subsequently 
cleaned, hairs trimmed and dorsal full thickness skin excised by blunt dissection, 
whilst being continually bathed in Hanks buffer. The skin sheets were then cut into 2 
cm2 sections and used immediately. 
 Topical delivery was performed using all-glass Franz diffusion cells (FDC) 
[19] which had a nominal diffusional area of 0.88 cm2 and receptor phase volume of 3 
mL. The skin was mounted stratum corneum uppermost on the lightly pre-greased 
flanges of the receptor and the donor chamber was placed on top of the membrane and 
clamped into position. A micro-stirrer bar was added to the receptor compartment, 
filled with degassed Hanks buffer as the receptor phase, and the sampling arm capped. 
The complete cells were placed on a multiple stirrer plate in a thermostatically 
controlled water bath set at 37°C for 15 min to allow the temperature to reach 
equilibrium prior to dosing (Table 1). A dose of 1 mL of the solutions was applied, 
with the intention of showing a maximal effect, rather than simulate an in-use 
scenario. At predetermined times the cells were dismantled and the skin membranes 
retained, prior to biological analysis or tape stripping.  
 
2.5. Western Blotting (WB) Analysis of COX-2 
The test solutions of PRE, PRE + ZnSO4, ZnSO4, TPT, TFF and control (phthalate 
buffer pH 4.5) were applied to ex vivo full thickness porcine skin within a Franz 
diffusion cell for 6 h. SDS PAGE and Western blotting was then carried out for COX-
2, as an inflammatory marker, and β-Actin, as the protein loading control.   
 The relative levels of expression of the inflammatory enzyme COX-2 were 
quantified following liberation from the tissue by skin lysis [20]. To prepare the skin 
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lysates, the diffusional areas of the skin were carefully excised by scalpel, cut into 
small pieces and added to 1 mL RIPA lysis buffer; the protease inhibitors were added 
immediately prior to homogenising for 1 min using a probe instrument (Silverson, 
Chesham, UK). Lysates were incubated for 15 min on ice then pelleted by 
centrifugation at 1400 g for 2 x 15 min at 4°C and the supernatant stored at -20°C. 
Methods for protein estimation and denaturation, polyacrylamide gel electrophoresis 
and Western blot analysis, are all described in detail elsewhere, and the method has 
previously been validated by showing the effect of known anti-inflammatory drugs as 
positive control: ketoprofen, ibuprofen and betamethasone dipropionate [4,5,21]. 
 
2.6. Immunohistochemical (IHC) Analysis of COX-2  
 
To supplement the Western blotting data the relative levels of COX-2 expression in 
skin were visualised using immunohistochemistry (IHC) which refers to the process 
of detecting antigens (e.g. proteins) in cells of a tissue section by exploiting the 
principle of antibodies binding specifically to antigens in biological tissues [22]. This 
process then allows qualitative or semi quantitative analysis of anti-inflammatory 
effect by comparing the COX-2 levels as indicated by colour intensity, whereby 
greater intensity indicates higher analyte concentrate and lower intensity indicates 
lower analyte concentration. The method as used in these laboratories is explained in 
detail elsewhere [4]. 
 
 
2.7. Penetration Depth Profiling 
 Tape stripping is widely used for the comparative estimation of the skin 
penetration of xenobiotics from topically applied formulations [19,23,24]. At 24 h 
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post-dosing, the skin was recovered from the FDC and excess formulation carefully 
removed using cotton buds. Regular Sellotape pieces, approx. 2.5 cm in length, were 
then applied over the diffused area and light pressure applied, before removal with 
forceps. The first two strips were discarded as they typically contain formulation 
lodged within the crevices of the skin surface, rather than being deposited within the 
tissue. Further tape pieces were then applied to the same area using uniform pressure 
and removed with uniform force, before being placed in screw capped glass vials and 
extracted with 4 mL methanol using an electronic rocker for 24 h. The strips were 
then removed and the methanol evaporated to dryness before the residue was 
reconstituted with 1mL deionised H2O. This was then centrifuged at 15000 g for 15 
min and the supernatant transferred to an autosampler vial, before being analysed for 
punicalagin by HPLC and zinc by ICPMS. 
 
2.8. Analysis of Punicalagin by Reverse-Phase High Performance Liquid 
Chromatography (HPLC) 
 
 In this work punicalagin was used as marker for PRE – punicalagin (Figure 1) 
is the tannin in highest concentration in PRE and has previously been shown to exert 
the greatest effect on Herpes simplex virus in combination with zinc (II) [6]. The 
analysis was performed using an Agilent series 1100 HPLC system fitted with a 
Phenomenex Gemini NX C18 110Å 250 x 2.6 mm column. Gradient elution was used, 
involving A = methanol with 0.1% trifluoroacetic acid (TFA) and B = deionised H2O 
with 0.1% TFA: 0 min A 5% B 95%, 15 min A 20% B 80%, 30 min A 60% B 40%, 
258nm. Punicalagin naturally occurs as a pair of anomeric isomers, α and β, in the 
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ratio of 1:2 (Figure 1). Aqueous solutions of punicalagin standard were analysed over 
a range of concentrations and the resulting calibration curves of the α and β anomers 
were used to determine total punicalagin levels by summation of the areas of the two 
corresponding peaks in the test sample chromatograms. 
 
2.9. Analysis of Zinc by Inductively Coupled Plasma Mass Spectrometry (ICPMS) 
 
 The levels of zinc permeating the skin were determined by ICPMS analysis 
[25] using a Thermo Elemental X Series 2 ICP-MS system equipped with a Plasma 
Screen. Calibration was carried out using synthetic standard solutions prepared from 
single element stock standards and analysis was performed by injecting each solution 
using 66Zn as the analytical mass. Periodic checks for accuracy were performed by 
analysis of a solution of the international rock standard JB1a as an unknown - this 
standard was prepared by digesting a sample in HF/HNO3 and then HNO3. The 
resulting concentration data were plotted as cumulative permeation versus time (n=3 
± SD).  
 
 
2.10. Data Analysis 
 
 The Western blot bands were scanned and analysed using a densitometer (GS-
690 Imaging Densitometer, Bio-Rad Laboratories Ltd, Herts, UK) equipped with 
Alpha DigiDoc software. The data obtained was recorded and analysed using Excel 
2007 (Microsoft office, Redmond, WA). Each experiment was performed in triplicate 
for each sample and the result expressed as the mean ± SD Statistical analysis was 
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carried out with InStat for Macintosh, version 3.0 (GraphPad Software Inc, San Diego, 
CA). 
3. Results and Discussion 
3.1. Western Blotting of Skin Lysate for COX-2 
 COX-2 is an inducible enzyme that is generally expressed only in cells where 
prostaglandins are upregulated, e.g., during inflammation. It is short-lived with a 
lifespan of 1-2 min at Vmax and is permanently inactivated after converting a few 
hundred arachidonic acid molecules [26]. Freshly excised porcine skin contains 
elevated levels of the COX-2 under viable conditions and it will continue to be 
produced until an anti-inflammatory agent is present that can block the enzyme or 
interfere with another part of the inflammatory pathway, or the tissue loses viability. 
Viability can be maintained in FDCs using certain media, in this current work we 
used HEPES buffered Hanks’ balanced salt solution (27). This technique has 
previously been used in our laboratories to examine the potential anti-inflammatory 
effects of a wide range of compounds applied to skin [4,5,21]. In doing so, such work 
has the added advantage of simultaneously verifying whether or not a permeant 
compound penetrates the skin in sufficient levels to enable it to act upon cellular 
COX-2. Clearly, no step in the arachidonic acid pathway can be modulated if 
insufficient compound penetrates to the dividing cells of the viable epidermis. 
Figure 2 shows the bands produced by WB analysis for COX-2 expression at 
~ 72 kDa and the protein loading control of β-actin at ~42 kDa. Densitometric 
measurements of the bands for COX-2 were normalised using β-actin; levels of COX-
2 expression in the control were arbitrarily assigned a value of 100% and test 
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solutions were shown as a percentage of the control and graphically displayed as a 
histogram. The application of PRE and PRE + ZnSO4 both led to the statistically 
significant (p>0.01) reduction of COX-2 expression by 66.5 ± 3.6 % and 64.5 ± 5.1 % 
respectively. Application of ZnSO4 had no significant (p>0.05) effect on the level of 
COX-2 expression. The reduction of COX-2 by PRE was similar to that reported 
previously [28] where it was shown a COX-2 reduction of 79% in colon cancer cells, 
and the lack of COX-2 reduction by the application of ZnSO4 at this concentration has 
also been previously shown [29]. Previous work using this ex vivo skin model 
confirmed anti-inflammatory activity from known anti-inflammatory agents included 
as positive control [4,5,21]. 
No reduction in COX-2 expression was observed using TFF, indicating that 
the components eliciting the major anti-inflammatory effect are the tannins. COX-2 
was downregulated following the application of TPT at 40.5%, but this level was 
significantly higher (by 26%) than the result obtained from PRE, in the presence or 
absence of ZnSO4. The reduction in COX-2 expression is greatest when PRE 
remained as a whole extract, with TPT (with its high punicalagin content) exhibiting 
anti-inflammatory activity, although to a lesser extent - this is again similar to 
reported findings [18]. 
 
3.2. Immunohistochemical (IHC) Staining of Ex Vivo Skin for COX-2 
 
 To verify the results observed from the WB experiments, samples were 
subject to visual analysis using IHC.  As expected, high levels of COX-2 was clearly 
observed in the untreated control skin at 0 h, as shown by the dark brown staining 
(Figures 3 & 4), after 6 h the degree of staining, and thus the inflammation, is 
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sustained and that by 24 h the COX-2 level increased (Figure 3). Previous work has 
shown that after 24 h necrosis occurs in such skin samples, making the determination 
of further time points impossible [4]. Figure 3 also shows that after 6 h treatment with 
PRE there was a clear reduction in COX-2, and a similar reduction was observed after 
the application of PRE + ZnSO4 combined. The level of COX-2 expression, after 
application of PRE alone and in combination with ZnSO4, was further reduced over 
24 h as shown by the lighter staining observed in Figures 3 & 4 at this time point. 
Application of ZnSO4 was found to have no effect on the level of COX-2 expression 
over the 24 h timescale. IHC analysis thus provided visual qualitative confirmation 
that the topical application of PRE (with and without ZnSO4) reduced COX-2 
expression in the ex vivo skin, which indicates a reduction in the inflammatory 
response. This is in agreement with several previous reports. Oral dosing of 
pomegranate to mice was reported to inhibit UVB-induced inflammation by 
modulating NF-κB and MAPK signalling [30]. Other work reported the pretreatment 
of rat primary microglia with punicalagin (5-40 μM) prior to LPS (10 ng mL-1) 
stimulation which produced a significant (p < 0.05) inhibition of TNF-α, IL-6 and 
prostaglandin E2 production; protein and mRNA expressions of COX-2 and 
microsomal prostaglandin E synthase 1 were also reduced by punicalagin 
pretreatment [31]. 
 Results from the current work demonstrate that the topical application of TPT 
and particularly PRE to skin affects the arachidonic acid inflammation pathway by 
downregulating the expression of COX-2. This suggests the biosynthesis in the viable 
epidermis may be blocked by one or more compound [3,15], although other steps 
such as DNA interaction or prostaglandin sequestration could feedback to produce a 
similar result. Nevertheless, reduction in COX-2 expression was statistically 
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significant after 6 h and was maintained up to 24 h - as this occurred in skin with an 
intact stratum corneum this shows that punicalagin and other components of PRE and 
TPT are able to penetrate the skin despite being large molecules, in agreement with 
our other work [32]. When PRE and ZnSO4 were applied in combination a 
statistically similar downregulation of COX-2 was observed when compared to the 
application of PRE alone, illustrating no modulatory effect of the presence of the zinc 
(II), and there was no evidence of anti-inflammatory activity following the application 
of ZnSO4 over this time period, in agreement with other work [33]. Our earlier paper, 
involved the topical application a PRE and zinc sulphate hydrogel, and showed that 
anti-inflammatory activity was retained by the permeants in FDC receptor phases that 
were then used to dose ex vivo skin, using the methods described in the current paper 
[34].  
 Using a commercial MTS kit, previous work has shown the absence of 
cytotoxicity of the solutions used in the current work [6]; indeed cytotoxic effects, if 
they occurred, might be expected to upregulate COX-2 and be observed in the current 
results [35]. As there was no evidence of this, the conclusion is that the formulations 
are not cytotoxic at the levels used. 
 
3.2. Depth profiles of Punicalagin and Zinc 
 
 To further prove that the anti-inflammatory effects observed above were 
entirely attributable to the penetration of PRE, we next determined the penetration of 
punicalagin and zinc within the skin. The permeation (i.e. delivery into and out from 
the membrane) of punicalagin and zinc across skin and mucosal membranes prone to 
HSV infection has been recently published [34]. Here we were concerned with 
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establishing the levels localised within skin and that constitute a drug reservoir [19], 
as this would clearly have a bearing on the ability of the applied dose to modulate 
skin inflammation processes as observed above. Tape stripping is a crude analytical 
technique that is widely used for the comparative determination of skin penetration 
[23,24], although specific mapping of strips to epidermal stratification yields more 
precision in determining drug localisation.  Nevertheless, on a purely relative basis, 
Figure 5 shows that the penetration of punicalagin was quite constant throughout each 
layer of the epidermis after 24 h, although higher amounts in the upper layers would 
typically be observed [19,36].  Here, by far the greatest recovery was from the 
remaining skin (i.e. remaining epidermis and dermis) and reflects the elevated levels 
observed in the basal layer by the technique of reverse-tape stripping [34]. The 
amount of punicalagin recovered in each layer of the epidermis after application of 
PRE and application of PRE + ZnSO4 was in the region of 0.1- 0.2 nM cm
-2 and 0.05 
- 0.1 nM cm-2 respectively. No penetrant peaks were observed for the control, as 
expected. The level of punicalagin after the application of PRE was 2.39 ± 0.29 nM 
cm-2. After application of PRE and ZnSO4 the concentration of punicalagin was 
somewhat lower at 3.3 ± 0.47 nM cm-2 (p < 0.05). The total recovery of punicalagin 
after application of PRE and PRE + ZnSO4 from the tape strips and the dermis was 
not statistically different (p>0.05) at 3.58 ± 0.1 nM cm-2 and 3.91 ± 0.62 nM cm-2 
respectively. These results are consistent with the permeation of punicalagin through 
the epidermis after application of 40 µL of PRE (1 mg mL-1) and PRE (1 mg mL-1) + 
ZnSO4 (1M) [6]. 
 As shown in the skin permeation experiment, punicalagin delivery occurred 
within the first three to six hours after application [34] and suggests that the 
punicalagin recovered in each of these layers after 24h application time had reached a 
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point of equilibrium. Figure 3 shows that a greater amount of punicalagin localised 
within the remaining skin when PRE was applied in combination with ZnSO4 and that 
punicalagin had a more even distribution through the stratum corneum and dermis 
after the application of PRE alone, the reason for the differences is unclear but may 
involve a complexation or co-permeation mechanism [37].  
 Figure 6 shows the amount of zinc recovered from the tape stripping of full 
thickness porcine skin after the topical application of 40 µL PRE (1 mg mL-1) + 
ZnSO4 (1 M), ZnSO4 (1 M) and control (pH 4.5 phthalate buffer) in vitro. The control 
shows that significant endogenous zinc leached from the porcine skin. Zinc was 
recovered from the porcine skin within each layer of the stratum corneum and within 
the dermis the total quantity recovered was 68.03 ± 5.6 nM cm-2 - this value is 
comparable with that reported previously [38]. The concentration of zinc recovered 
was greatest and significantly different (p>0.05) after the application of ZnSO4 and 
PRE + ZnSO4, this remained true at all layers of the stratum corneum. The highest 
levels were again extracted from the remaining skin – remnant epidermis and dermis. 
This could be due to preferential binding to the basal layer and/or the small size of the 
zinc (II) atom lead to rapid delivery into the receptor phase.   
 Overall, dosing of PRE and ZnSO4 to ex vivo porcine skin indicates that 
punicalagin, the major virucidally active polyphenolic tannin within PRE, and zinc 
penetrate throughout the epidermis, supporting our work in relation to skin 
permeation [34]. However, the greater amounts of both analytes in the remaining skin 
may, given the polar nature of the analytes and the vehicles, may also reflect the 
importance of the appendageal delivery routes, in particular via the sweat pores.  
These are found over the entire body with a density of 400 glands cm-2 and have the 
purpose of exuding sweat, an aqueous electrolyte solution [39]. Given the clear anti-
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inflammatory effects observed, such channels could provide a short-cut by allowing 
the permeants to bypass the barrier function of the stratum corneum which is 
primarily lipoidal in nature. This is sometimes referred to as a ‘shunt route’ [40], and 
also goes some way to explaining the amounts founds in relation to their 
physicochemical properties: the molecular weights of punicalagin and zinc (II) are 
1084 and 65 respectively, both markedly different to the generally accepted maximum 
of ~400 [19] and unfavourable fitting to the Potts and Guy algorithm (not shown) [41]. 
Such may have been facilitated by the infinite dosing of a liquid vehicle, although it 
should be noted that our previous paper involving a hydrogel formulation [34] also 
revealed significant COX-2 downregulation in ex vivo skin. Generally, a molar excess 
of zinc were found in the tape strips relative to punicalagin, reflecting the different 
loading concentrations.  
4. Conclusions 
 The current findings show that topically applied TPT and PRE, with or 
without zinc (II), exert a significant anti-inflammatory effect on COX-2 expression in 
ex vivo skin. Indirectly, this demonstrates that the anti-inflammatory principles, in 
particular punicalagin, penetrate the skin and modulate COX-2 expression; 
penetration into skin was further supported by tape stripping data. Pomegranate 
extracts are generally safe [42,43] and could therefore represent a novel approach in 
ameliorating the inflammation and pain associated with a range of skin conditions. 
When considered alongside the potent virucidal activity [6], there is the basis of a 
dual action therapeutic system for HSV infections, such as coldsores, anogenital 
herpes and herpetic stromal keratitis. 
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Legends to figures 
 
Figure 1 Chemical structure and high performance liquid chromatography 
chromatogram of punicalagin, showing the 1:2 proportions of  and  anomers. 
 
 
Figure 2 Analysis of cyclooxygenase-2 (COX-2) protein expression by Western 
blotting. Full thickness porcine skin was treated with topical ZnSO4 (1 M), 
pomegranate rind extract (PRE) (1 mg mL-1), PRE (1mg mL-1)  + ZnSO4 (1 M) and 
phthalate buffer as a control for 6 h, protein was extracted and 30 µg was loaded and 
separated via SDS-PAGE (sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis). The histogram represents COX-2 (72kDa) levels normalised against 
β-actin (42 kDa). Levels in control were arbitrarily assigned a value of 100% (n=3 ± 
SD). 
 
Figure 3 Immunohistochemical staining of porcine skin for cyclooxygenase-
2 (COX-2) at 0h, 6h, and 24h after the topical application of control 
(phthalate buffer pH 4.5) and pomegranate rind extract (1 mg mL-1) (40x 
magnification). Darker shading is due to higher COX-2 presence, lighter 
shading is due to lower COX-2 presence (representative of 3 
determinations). 
 
Figure 4 Immunohistochemical staining of porcine skin for cyclooxygenase-
2 (COX-2) at 0h, 6h, and 24h after the topical application of PRE (1 mg mL-
1) + ZnSO4 (1 M) and ZnSO4 (1 M) (40x magnification). Darker shading is 
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due to higher COX-2 presence, lighter shading is due to lower COX-2 
presence. 
 
Fig 5 Depth profile of punicalagin () in porcine skin after application of 
pomegranate rind extract (PRE) (green), PRE + ZnSO4 (red) and control (blue) (n=3 ± 
SD). 
 
Fig 6 Depth profile of zinc recovered from the tape stripping of full thickness porcine 
skin after 24h application of pomegranate rind extract (1 mg mL-1) + ZnSO4 (1 M), 
ZnSO4 (1M) and control (n=3 ± SD).
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Figure 4 
PRE + ZnSO4  0h PRE + ZnSO4  6h PRE + ZnSO4  24h 
   


































































Test solution Vehicle Molecular biology 
technique 
PRE 0.1 mg mL-1 in phthalate buffer pH 4.5 Immunohistochemistry 
Western Blotting 
ZnSO4 0.1 M in phthalate buffer pH 4.5 Immunohistochemistry 
Western Blotting 
PRE + ZnSO4 PRE 0.1 mg mL
-1, ZnSO4 0.1 M, 
phthalate buffer pH 4.5 
Immunohistochemistry 
Western Blotting 
Control Phthalate buffer pH 4.5 Immunohistochemistry 
Western blotting 
TPT 0.1 mg mL-1 in phthalate buffer pH 4.5 Western blotting 
TFF 0.1 mg mL-1 in phthalate buffer pH 4.5 Western blotting 
Table 1 Test solutions and molecular biology techniques employed in the assessment 
of anti-inflammatory activity in ex vivo skin (PRE = pomegranate rind extract, TPT = 
total pomegranate tannins, TFF = tannin-free fraction). 1mL of test solution dosed in 
each case, n=3. 
 
